16-89100803-A-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001243279.3(ACSF3):c.122A>T(p.Asp41Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,612,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D41Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_001243279.3 missense
Scores
Clinical Significance
Conservation
Publications
- combined malonic and methylmalonic acidemiaInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000854  AC: 13AN: 152212Hom.:  0  Cov.: 34 show subpopulations 
GnomAD2 exomes  AF:  0.0000121  AC: 3AN: 248798 AF XY:  0.0000148   show subpopulations 
GnomAD4 exome  AF:  0.0000116  AC: 17AN: 1460334Hom.:  0  Cov.: 102 AF XY:  0.0000110  AC XY: 8AN XY: 726514 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000853  AC: 13AN: 152330Hom.:  0  Cov.: 34 AF XY:  0.0000805  AC XY: 6AN XY: 74488 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Combined malonic and methylmalonic acidemia    Uncertain:2 
- -
This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 41 of the ACSF3 protein (p.Asp41Val). This variant is present in population databases (rs545886514, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ACSF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 565935). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases    Uncertain:1 
The c.122A>T (p.D41V) alteration is located in exon 3 (coding exon 1) of the ACSF3 gene. This alteration results from a A to T substitution at nucleotide position 122, causing the aspartic acid (D) at amino acid position 41 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at